NCT01349985View on ClinicalTrials.gov

Adaptive Goal-Directed Adherence Tracking and Enhancement

PHASE2CompletedINTERVENTIONAL

Enrollment

136

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions

Alcohol Abuse

Interventions

OTHER

AGATE

AGATE is a web-based adherence-enhancement intervention accessible via smartphone. All participants will be prescribed naltrexone, 50 mg, once daily for eight weeks.

OTHER

SASED

Participants will receive SASED, a web-based alcohol and side-effects diary via smartphone. All participants will be prescribed naltrexone, 50 mg, once daily for eight weeks.

Trial Locations (1)

87106

The Mind Research Network, University of New Mexico, Albuquerque

All Listed Sponsors

collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

Talaria, Inc

INDUSTRY

NCT01349985 - Adaptive Goal-Directed Adherence Tracking and Enhancement | Biotech Hunter | Biotech Hunter